This site is intended for health professionals only

Editor’s pick

New therapeutic indication authorised for GSK’s Tyverb (lapatinib)
New therapeutic indication authorised for GSK’s Tyverb (lapatinib)
Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease
Merck to initiate proof-of-concept study of posaconazole for chronic chagas disease
Statins “prevent prostate cancer”
Statins “prevent prostate cancer”
Epratuzumab data from phase IIb EMBLEM study
Epratuzumab data from phase IIb EMBLEM study
New therapeutic indication authorised for GSK’s Tyverb
New therapeutic indication authorised for GSK’s Tyverb
Pfizer ends osteoarthritis drug trial
Pfizer ends osteoarthritis drug trial
Drug hope follows gene discovery
Drug hope follows gene discovery
MAP reports positive migraine data
MAP reports positive migraine data
Merck to target new markets
Merck to target new markets
Stryker announces election of new director
Stryker announces election of new director
Lucentis to treat sudden blindness
Lucentis to treat sudden blindness
Approval for APP infection drug
Approval for APP infection drug
1 … 57 58 59 60 61 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x